Scrip: The Importance Of Early Planning In Cell & Gene Therapy Commercialization

This panel will identify successful strategies that underpin currently-marketed therapies and examine how establishing a framework early in development helps keep long-term production and commercialization goals on track.  

Matthew Durdy, Chief Executive Officer

Panel: The Importance Of Early Planning In Cell & Gene Therapy Commercialization 


  • Jeffrey Hung, Chief Commercial Officer – Vigene Biosciences
  • Shesh Sharma, Sr. Director, Clinical Stage CAR-T – Innolynx
  • Matthew Durdy, Chief Executive Officer - Cell and Gene Therapy Catapult
  • Timothy P. Bradshaw, Executive Director, Center of Global Drug Development – PRA

Wednesday 25 August, 15:00 BST

Register here!

Discover who we are